Project Grant R25AG088409
Award Date
9/5/24
Completion Date
8/31/29
Dollars Obligated
$263K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Troy, NY, USA
Similar Awards
This $500,000 Project Grant was awarded on September 15, 2024 by the National Institute on Aging (CFDA 93.866 Aging Research program) to Neucyte Inc., a minority-owned small business specializing in advanced biomedical research and development. The funding will support the development of a miniaturized "mini-brain" microphysiological system (MPS) platform using Alzheimer's disease (AD) patient-derived cells. The goal is to create a scalable, reproducible in vitro brain model that can...
The National Institute on Aging (NIA) awarded a Project Grant (CFDA 93.866 - Aging Research) in the amount of $661,016 to the University of Southern California (USC) to develop a "Federated Deep Learning to Accelerate Alzheimer's Disease Research" project. The key products and services to be delivered include: Establishing an international "Federate AD" alliance to leverage innovative AI techniques and distributed computation to study Alzheimer's disease (AD) across large,...
The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...
This $270,000 Project Grant award from the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) aims to provide comprehensive training in translational aging research and diverse career paths across academia, industry, and entrepreneurship. The award will support 15 doctoral or postdoctoral trainees over a 5-year period, enabling them to pursue research in aging while also gaining practical experience in various dimensions of translational research,...
This $6,226,692 project grant award from the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) will support research to examine the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the development of Alzheimer's disease (AD). The primary focus is on investigating how modifications in brain activity, particularly in the locus coeruleus (LC) and hippocampus (HPC) regions, can lead to the key pathological hallmarks of AD....
The National Institute on Aging awarded a $1,931,965 Project Grant (CFDA 93.866 - Aging Research) to the Regenerative Research Foundation, a non-profit organization in Albany, New York. The purpose of this federal grant is to develop and validate a novel human induced pluripotent stem cell (iPSC) model that incorporates cerebral cortical neurons, glia, vascular endothelial cells, and microglia to study cerebrovascular interactions in Alzheimer's disease-related dementias (ADRD). The R61 phase of...
This federal Project Grant award of $340,632 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of an interdisciplinary training program at Arizona State University (ASU) to nurture 9-10 predoctoral trainees annually in Alzheimer's disease (AD) and AD-related dementia (ADRD) research. The program leverages AD/ADRD resources in Arizona and engages partners like the Arizona Alzheimer's Consortium, Arizona Alzheimer's Disease Research Center, Mirabella...
The National Institute on Aging (NIA) awarded a $232,719 Project Grant under the Aging Research program (CFDA 93.866) to The Regents of the University of California, Berkeley (UC Berkeley) to develop and deliver the IMPRINT (Immersive Methods for Promoting Research and Innovations through Novel Training) program. IMPRINT will provide a one-year, hybrid training program for 12-15 graduate students and postdoctoral fellows, combining immersive in-person sessions with remote coursework. The program...
This $585,650 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund the "Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)" at Emory University over a 5-year period from September 2024 to August 2029. The program aims to train a diverse cohort of 4 pre- and post-doctoral candidates annually to develop expertise in leveraging "big data" approaches to advance the understanding and treatment of Alzheimer's...
The National Institute on Aging (NIA) awarded a $514,862 Project Grant (CFDA 93.866 - Aging Research) to Neuroindx, a for-profit, woman-owned small business, to develop an on-chip functional assay for identifying candidate microtubule-binding drugs to treat Alzheimer's Disease and related disorders (ADRDs). The goal of the project is to create an in vitro assay that can replicate key features of the neuronal microtubule microenvironment and use kinesin-based readouts to measure the ability of...